Literature DB >> 29363180

Separate roles of IL-6 and oncostatin M in mouse macrophage polarization in vitro and in vivo.

Anisha Dubey1,2, Laura Izakelian1,2, Ehab A Ayaub1,2, Lilian Ho1,2, Kyle Stephenson1,2, Steven Wong1,2, Karen Kwofie1,2, Richard C Austin2,3, Fernando Botelho1,2, Kjetil Ask1,4,3, Carl D Richards1,2.   

Abstract

Arginase-1 (Arg-1)-expressing M2-like macrophages are associated with Th2-skewed immune responses, allergic airway pathology, ectopic B16 melanoma cancer growth in murine models, and can be induced by Oncostatin M (OSM) transient overexpression in vivo. Here, we compare OSM to the gp130-cytokine IL-6 in mediating macrophage polarization, and find that IL-6 overexpression alone (Ad vector, AdIL-6) did not induce Arg-1 protein in mouse lungs at day 7, nor ectopic melanoma tumor growth at day 14, in contrast to overexpression of OSM (AdOSM). AdOSM elevated levels of IL-4, IL-5 and IL-13 in bronchoalveolar lavage fluid, whereas AdIL-6 did not. Bone marrow-derived macrophages respond with Arg-1 enzymatic activity to M2 stimuli (IL-4/IL-13), which was further elevated in combination with IL-6 stimulation; however, OSM or LIF had no detectable activity in vitro. Arg-1 mRNA expression induced by AdOSM was attenuated in IL-6-/- and STAT6-/- mice, suggesting requirements for both IL-6 and IL-4/IL-13 signaling in vivo. Ectopic B16 tumor burden was also reduced in IL-6-/- mice. Thus, OSM induces Arg-1+ macrophage accumulation indirectly through elevation of Th2 cytokines and IL-6 in vivo, whereas IL-6 acts directly on macrophages but requires a Th2 microenvironment, demonstrating distinct roles for OSM and IL-6 in M2 macrophage polarization.
© 2017 Australasian Society for Immunology Inc.

Entities:  

Keywords:  Interleukin-6; Oncostatin M; lung cancer; macrophage arginase activity

Mesh:

Substances:

Year:  2017        PMID: 29363180     DOI: 10.1111/imcb.1035

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  6 in total

1.  LncRNA MIAT downregulates IL-1β, TNF-ɑ to suppress macrophage inflammation but is suppressed by ATP-induced NLRP3 inflammasome activation.

Authors:  Ziye Wang; Yang Kun; Zhao Lei; Wen Dawei; Pan Lin; Wang Jibo
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

2.  RELMα is Induced in Airway Epithelial Cells by Oncostatin M Without Requirement of STAT6 or IL-6 in Mouse Lungs In Vivo.

Authors:  Lilian Ho; Ashley Yip; Francis Lao; Fernando Botelho; Carl D Richards
Journal:  Cells       Date:  2020-05-27       Impact factor: 6.600

3.  Extracellular Matrix and Fibrocyte Accumulation in BALB/c Mouse Lung upon Transient Overexpression of Oncostatin M.

Authors:  Fernando M Botelho; Rebecca Rodrigues; Jessica Guerette; Steven Wong; Dominik K Fritz; Carl D Richards
Journal:  Cells       Date:  2019-02-05       Impact factor: 6.600

Review 4.  Oncostatin M, an Underestimated Player in the Central Nervous System.

Authors:  Evelien Houben; Niels Hellings; Bieke Broux
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

5.  IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections.

Authors:  Saadé Kheir; Bérengère Villeret; Ignacio Garcia-Verdugo; Jean-Michel Sallenave
Journal:  Mol Ther       Date:  2021-08-08       Impact factor: 11.454

Review 6.  Mitochondrial DNA on Tumor-Associated Macrophages Polarization and Immunity.

Authors:  Yaxin Guo; Hsiang-I Tsai; Lirong Zhang; Haitao Zhu
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.